Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations ...
Pfizer’s (PFE) stock has fallen ill since the COVID-19 pandemic waned, and it is still experiencing some aftereffects. The ...
Formation Bio, an AI-driven pharmaceutical company revolutionizing drug development, today announced that Mikael Dolsten, MD, PhD, former Chief Scientific Officer and President, Pfizer Research & ...
Public health leaders looked to UNC-Chapel Hill virologist Ralph Baric to end the pandemic. Their critics blamed it on him.
The "buy the dip" strategy worked flawlessly for over two years. Any significant drop in the stock market led to a sharp ...
A new study found that reported diagnoses for tuberculosis were consistently lower than expected throughout the pandemic, even though incarceration rates remained largely consistent and TB detection ...